Related Experiment Video

Updated: Apr 26, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

10.0K

Personal neoantigen cancer vaccines: The momentum builds

Edward F Fritsch1, Nir Hacohen2, Catherine J Wu3

  • 1Broad Institute of Harvard and MIT; Cambridge, MA USA ; Department of Medical Oncology; Cancer Vaccine Center; Dana-Farber Cancer Institute; Boston, MA USA.

Oncoimmunology
|August 8, 2014
PubMed

Insights

Neoantigen cancer vaccines, targeting patient-specific mutations, are revitalizing cancer treatment. These personalized vaccines are crucial for immune control of cancer and are now in clinical trials.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Neoantigens are tumor-specific mutations that elicit an immune response.
  • Cancer vaccines targeting neoantigens offer a personalized approach to cancer immunotherapy.
  • Previous cancer vaccine strategies have faced challenges, but neoantigen vaccines show promise.

Purpose of the Study:

  • To highlight the significance of neoantigens in cancer immunity.
  • To discuss the current status and potential of neoantigen-based cancer vaccines.
  • To acknowledge the challenges and future directions in neoantigen vaccine development.

Main Methods:

  • Review of current data on neoantigen discovery and immunogenicity.
  • Analysis of clinical trial outcomes for neoantigen vaccines.
  • Discussion of manufacturing processes and optimization strategies.

Main Results:

  • Growing evidence supports the critical role of neoantigens in controlling cancer growth.
  • Neoantigen vaccines are demonstrating potential in clinical evaluations.
  • Manufacturing complexity remains a significant hurdle, alongside other challenges.

Conclusions:

  • Neoantigen vaccines represent a promising advancement in personalized cancer therapy.
  • Further research and development are needed to overcome manufacturing and clinical challenges.
  • Neoantigen-based vaccines are poised to become an important tool in cancer treatment.
Keywords:
T cellscentral toleranceneoantigenpersonalizedvaccine

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

10.9K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.1K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.4K